Enlivex Therapeutics
ENLV
ENLV
24 hedge funds and large institutions have $3.99M invested in Enlivex Therapeutics in 2024 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 4 closing their positions.
Holders
24
Holders Change
+5
Holders Change %
+26.32%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
8
Reduced
3
Closed
4
Calls
$15K
Puts
$11K
Net Calls
+$4K
Net Calls Change
-$42K
Top Buyers
1 |
1
Millennium Management
New York
|
$742K |
2 |
2
Renaissance Technologies
New York
|
$186K |
3 |
AC
3
Armistice Capital
New York
|
$2.58M |
4 |
4
Morgan Stanley
New York
|
$315K |
5 |
TSS
5
Two Sigma Securities
New York
|
$26.2K |